Dr. Ricardo Rossello is an innovative scientist, best-selling author, distinguished professor, and former Governor of Puerto Rico, giving him a rare combination of achievements across a range of elite disciplines. Dr. Rossello is currently the Chief Vision Officer of the Regenerative Medicine Institute, a global leader in longevity and stem cell research. We spoke with him about the future of the science of life extension.
_______________
Q: Dr. Rosselló, what do you see as the biggest breakthrough in understanding longevity and aging?
RICARDO ROSSELLO: One of the most significant breakthroughs was the discovery of how cellular reprogramming can reverse biological aging. Shinya Yamanaka’s identification of four genes that can reset cells to an embryonic-like state opened the door to the possibility of slowing or even reversing aging at a fundamental level. Also, the development of epigenetic clocks has allowed us to precisely measure the biological aging process, which lets us design targeted interventions. The recognition of aging as a disease by the World Health Organization in 2022 spurred significant investment and innovation in this field. At RMI and with a nascent longevity fund, we are leveraging these advances to develop therapies that improve not just lifespan, but healthspan, which refers to the years we spend in good health.
Q: As the Chief Visionary Officer of RMI Health, you’ve focused heavily on personalized medicine. What advantages does this approach offer patients?
RICARDO ROSSELLO: Personalized medicine allows us to tailor interventions based on an individual’s unique biological profile. We analyze factors such as genomic data, gut microbiome composition, and epigenetic markers to create a customized “bio-blueprint” for longevity. We can then implement specific lifestyle changes and cellular therapies that address aging at its core. We’re looking for ways that we can adjust treatments and optimize outcomes that improve the overall quality of life for our patients.
Q: How do you address some of the ethical concerns around longevity research and access to treatment?
RICARDO ROSSELLO: This question is central to the research I have done. We are mindful that novel therapies lend themselves to exaggerated claims at best and snake oil at worst. At every stop, including RMI, my position has been to place the research and the outcomes first. Processes should go through rigorous clinical evaluation before being implemented. They must be, first and foremost, safe. We are also mindful that current treatments are expensive. This tends to be the path towards getting procedures democratized. Our mid-to-long-term goal is to develop scalable and affordable therapies that can be widely distributed. We want to extend and improve not just the length but also the quality of life, helping people remain healthy and active for longer.
Q: How is RMI Health utilizing AI to advance longevity science?
RICARDO ROSSELLO: The emergent properties with RMI and AI are boundless. It is the stuff of science fiction. Digital twins, instant patient-specific solutions, predictive medicine. We are constantly pushing ourselves to be at the forefront of AI and Biology. At RMI Health, we collaborate with data scientists to use AI for predictive modeling, optimizing treatment protocols, and uncovering new therapeutic targets. AI helps us personalize interventions more effectively by analyzing patient-specific genetic and epigenetic markers.
Q: Looking ahead, what do you envision for the future of longevity science, and what role will RMI Health play in it?
RICARDO ROSSELLO: We are at the dawn of a new era in longevity science. A Time Magazine article last week covered a new development in gene therapy that has the potential to act as a “biological rewind button” for optic-nerve cells, returning them to a pre-diseased state. Think about it. We can actually turn the clock back on cells. It is scientifically proven. Now, it is an engineering and clinical problem to apply it. There’s a real race to reverse time at a cellular level, and we’re excited to be a part of it. We have the potential to create a future where people live longer, healthier, and more vibrant lives.